The American Journal of Managed Care

Commercial FIT Capable of Similar Diagnostic Results as New Stool DNA Test

Commercial FITs can match NG-MSDT diagnostic results for CRC by lowering the positivity threshold, enhancing sensitivity while maintaining specificity. FITs are accessible, noninvasive CRC screening ...
Medscape

What to Know About the Next-Gen FIT for CRC Screening

Multitarget stool-based tests are showing promise for colorectal cancer (CRC) screening in average-risk individuals and could edge out the current standard fecal immunochemical test (FIT). These new ...
The American Journal of Managed Care

FIT Screening Found to Be Unsatisfactory in 10% of Submitted Tests

More than 10% of fecal immunochemical test (FIT)–based colorectal cancer screening could not be processed due to unsatisfactory samples. Colorectal cancer (CRC) screening using the fecal ...
Medscape

Molecular Stool Testing Could Cut Post-Polypectomy Colonoscopies by 15%-41%

Noninvasive surveillance with multitarget stool DNA testing or fecal immunochemical testing (FIT) could potentially match colonoscopy for reducing long-term colorectal cancer (CRC) incidence and ...
EurekAlert!

Lower education and mild cognitive impairment may hinder successful completion of home colorectal screening tests

While many patients find at-home colorectal cancer screening tests (known as fecal immunochemical tests or FIT) more comfortable than those performed in the clinic, FIT collection is dependent upon ...